Prostate cancer remains one of the most commonly diagnosed cancers among men worldwide, creating a significant demand for accurate and timely diagnostic solutions. Early detection plays a crucial role in improving treatment outcomes and survival rates, prompting healthcare providers to adopt advanced diagnostic technologies. Growing awareness regarding cancer screening, increasing healthcare...
The Bioinformatics industry in North America is witnessing steady growth as pharmaceutical companies and academic institutions invest heavily in data-driven drug discovery and precision medicine.
The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is estimated to grow at a CAGR of 15.7% from 2022 to 2028.
Key Factors Driving...
The Global Fluorescent In Situ Hybridization Probe Market is experiencing steady growth due to increasing demand for advanced molecular diagnostics, the rising prevalence of cancer and genetic disorders, and the growing adoption of precision medicine. Fluorescent in situ hybridization (FISH) is a molecular technique that uses fluorescently labeled DNA or RNA probes to identify and localize...
Global Mesotherapy Market Accelerates Rapidly as Minimally Invasive Aesthetics, Targeted Biorevitalization, and Advanced Transdermal Delivery Systems Reshape Cosmetic Dermatology
The global aesthetic medicine and dermatological intervention landscape is undergoing a decisive paradigm shift, transitioning from aggressive surgical procedures toward personalized, minimally invasive regenerative...
The North America Bioinformatics Platforms sector is expanding with increasing investment in genomics, biotechnology, precision medicine, and pharmaceutical research. Advanced computational infrastructure and strong R&D capabilities are supporting adoption.
The global bioinformatics platforms market size is projected to reach US$ 1,619.51 million by 2034 from US$ 644.19 million in...
Polaris Market Research presents its latest market research report, titled Agrigenomics Market Share, Size, Trends, Industry Analysis Report, 2026 - 2034. It is a comprehensive market research report analyzing the fast-evolving Agrigenomics market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth....
Polaris Market Research presents its latest market research report, titled Hereditary Testing Market Size and Share Global Analysis Report. It is a comprehensive market research report analyzing the fast-evolving hereditary testing market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The...
The Multiomics for Precision Medicine Market is witnessing significant transformation as pharmaceutical companies, biotechnology firms, research institutions, and healthcare organizations increasingly integrate multiple molecular data layers to improve disease understanding, biomarker discovery, treatment selection, and clinical decision-making. Polaris Market Research’s latest report,...
The latest report by IMARC Group, titled "US Prostate Cancer Biomarkers Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2026-2034", offers a comprehensive analysis of the industry, which comprises insights on the US prostate cancer biomarkers market. The report also includes competitor and regional analysis.
US Prostate Cancer Biomarkers Market Size Overview...
According to a new report by Polaris Market Research, the global multiomics for precision medicine market was valued at USD 1,707.5 million in 2025 and is projected to reach USD 7,014.8 million by 2034, expanding at a CAGR of 17.0% over the forecast period. Growth is underpinned by expanding linked patient cohorts, integrated multiomic workflows, and structured health-data regulation...
Precision Medicine Software Market: Key Segmentation, Growth Drivers, Trends and Recent Developments
The global Precision Medicine Software Market is experiencing significant growth as healthcare systems, pharmaceutical companies, research institutions, and biotechnology organizations increasingly use advanced software to support personalized diagnosis, treatment selection,...
"
According to the latest report published by Data Bridge Market Research, the Ovarian Cancer Diagnostics Market
The global ovarian cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.0% in the forecast period of 2023 to 2030 and is expected to reach USD 11,647.12...